Pharmaceuticals, Biotechnology and Life Sciences
Dr. Brent Boyett Joins ASAM’s Prestigious Board of Directors, Which Represents More Than 6,000 Addiction Medicine Professionals BIRMINGHAM, Ala.–(BUSINESS WIRE)–Pathway…
Data presented at 2019 ASCO Annual Meeting DURHAM, N.C.–(BUSINESS WIRE)–GeneCentric Therapeutics will present the first data on novel response signatures…
SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…
SEONGNAM-SI, South Korea–(BUSINESS WIRE)–Qurient Co. Ltd. today announced positive results from the Phase 2a EBA (early bactericidal activity) clinical trial…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced that it will be presenting…
Industry Veteran Brings Specialized Expertise in Medical Affairs, Medical Device and Real-World Evidence to Key Leadership Role in Fast-Growing Region…
PARIS–(BUSINESS WIRE)–Servier and Taiho Oncology, Inc. a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today presented LONSURF® (trifluridine/tipiracil, TAS-102) clinical…
SAN FRANCISCO–(BUSINESS WIRE)–Atomwise Inc. today announced a multi-year agreement with Eli Lilly and Company to apply Atomwise’s patented artificial intelligence…
Advocating on behalf of cancer survivors on June 4, 2019, National Cancer Survivors Day BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth a specialty-focused pharmaceutical…
– Phase 1/2 Data Being Presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting Demonstrated TAK-788 Extended…